Fortitude Advisory Group L.L.C.
Position in MGX — Metagenomi Therapeutics, Inc.
CIK 1928999
GIG HARBOR, WA
Position in MGX
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$49,834
-$12,924 QoQ
Shares Held
37,190
-4.0% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fortitude Advisory Group L.L.C. holds $49,834 across 1 Biotechnology name. MGX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MGX |
Metagenomi Therapeutics, Inc.
This page
|
37,190 | $49,834 |
All Filings in MGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49,834 | 37,190 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $62,758 | 38,740 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $91,813 | 38,740 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $56,965 | 38,490 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $50,034 | 36,790 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $273,421 | 75,740 | Shares | Sole | 2025-01-22 | |
| No filing history on record for this holder in this stock. | ||||||